Jhunjhunwala-backed Rare Enterprises holds 6-month lock-in post Concord Biotech listing
Concord Biotech's financial landscape has undergone notable shifts, with operational margins stabilising around 40-42% in 2023.
Stay updated with breaking news from Quadrant Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Concord Biotech's financial landscape has undergone notable shifts, with operational margins stabilising around 40-42% in 2023.
The Santo Domingos, one of South America's richest families, are in a $6 billion bid to buy the NFL's Washington Commanders, according to reports.
TSA Management expands into the United Kingdom with key acquisition
As sustainability became the market darling, Leandro Gastaldi stuck to his long-term thesis on oil in a pandemic-led marketplace and returns have rallied as a result.
Financial services luminaries have paid tribute to Pat Handley, the former chief financial officer of Westpac for seven years in the 1990s.